Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysisHELIYONIF3.62023-04-015OAAI
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysisAMERICAN JOURNAL OF KIDNEY DISEASESIF8.22023-04-0113PRE
A Novel Insight into the Role of PLA2R and THSD7A in Membranous NephropathyJOURNAL OF IMMUNOLOGY RESEARCHIF3.62021-07-1422OAAI
In response to Title: Letter to the Editor in response to the article 'Efficacy and safety of HIF prolyl hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis'PHARMACOLOGICAL RESEARCHIF10.52021-01-010PREAI
Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysisPHARMACOLOGICAL RESEARCHIF10.52020-09-0155PREAI
Efficacy of Intermittent or Continuous Very Low-Energy Diets in Overweight and Obese Individuals with Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysesJOURNAL OF DIABETES RESEARCHIF3.42020-01-2910OAAI
Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic ratsJOURNAL OF ENDOCRINOLOGICAL INVESTIGATIONIF3.52013-06-0130PREAI